PVCT Provectus Biopharmaceuticals - Comparative study shows Rose Bengal more efficiant than bevacizumab in treating corneal neovascular - PVCT Provectus Biopharmaceuticals - InvestorVillage


PVCT Provectus Biopharmaceuticals
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: PVCT Provectus Biopharmaceuticals   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  5935 of 5995  at  5/10/2021 10:03:09 AM  by

keahou

The following message was updated on 5/10/2021 10:06:10 AM.

 In response to msg 5934 by  leave_the_gun
view thread

Re: Comparative study shows Rose Bengal more efficiant than bevacizumab in treating corneal neovascularization.

 
  .......Avastin generates over $7 BILLION dollars in sales for Roche annually........
 
CYDY with a far better drug for Covid-19 has FDA moving gold posts on trials delaying it's life saving drug.  Protecting GILD's billions in revenue?  GILD donates millions to NIH and NIAID annually.  Fauci has been head of NIAID since 1984.
 
Perhaps the FDA will not do the same with PVCT as ROCHE may not do the same.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...